Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Innovent gears up for PD-1 inhibitor launch in China

Innovent gears up for PD-1 inhibitor launch in China The home-grown PD-1 inhibitors join Bristol-Myers Squibb and Merck &Co/MSD’s rival drugs on the Chinese market.

More good news, and some bad, for Merck’s Keytruda

More good news, and some bad, for Merck’s Keytruda The rare setback for Keytruda comes as it has started to show signs of lengthening its new lead in the PD1/PD-L1 inhibitor category over main rival Bristol-Myers Squibb

2019: CRISPR and therapeutic gene editing comes of age

2019: CRISPR and therapeutic gene editing comes of age The cells were gene-edited to lack PD-1, the immune checkpoint targeted by drugs such as Merck &Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab), and the

Merck puts prostate cancer firmly in Keytruda’s sights

Merck puts prostate cancer firmly in Keytruda’s sights Merck has competition in this area of course, and arch-rival in the cancer immunotherapy category, Bristol Myers Squibb, reported results at ASCO GU with its double immunotherapy combination of

CEOs agree to Congressional grilling on US drug prices

CEOs agree to Congressional grilling on US drug prices Now Pfizer’s Albert Bourla, Merck’s Ken Frazier, Sanofi’s Olivier Brandicourt and Bristol-Myers Squibb’s Giovanni Caforio have now all confirmed they will attend the finance committee hearings

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics